Alnylam Pharmaceuticals | Brutto Fortjeneste På Salg

Gross Profit On Sales Endring Dato
Acadia Pharmaceuticals USD 182.88M 30.27M 2024-03
Agios Pharmaceuticals USD 7.56M 1.04M 2024-03
Alnylam Pharmaceuticals USD 428.36M 74.5M 2024-03
Amgen USD 4.25B 837M 2024-03
BioMarin Pharmaceutical USD 523.65M 12.92M 2024-03
Incyte USD 819.89M 129.4M 2024-03
Ionis Pharmaceuticals USD 117.35M 204.1M 2024-03
Moderna USD 71M 1.81B 2024-03
Neurocrine Biosciences USD 507.8M 20.2M 2024-03
Novartis USD 9.02B 235M 2024-03
PTC Therapeutics USD 195.38M 82.56M 2024-03
Regeneron Pharmaceuticals USD 2.71B 206.1M 2024-03
Sanofi EUR 7.68B 1.18B 2024-03
Sarepta Therapeutics USD 362.9M 68.11M 2024-03
Takeda JPY 731.7B 32.2B 2023-12
Ultragenyx Pharmaceutical USD 91.3M 24.04M 2024-03
Vertex Pharmaceuticals USD 2.35B 183.2M 2024-03



Alnylam Pharmaceuticals Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.